Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Marina, N*" or (type exact bookEditor and editor="Marina, N*")

Add to list
- Journal Article
- A1
- open access
Linking EORTC QLQ-C-30 and PedsQL/PEDQOL physical functioning scores in patients with osteosarcoma

Axel Budde, Katja Baust, Leonie Weinhold, Mark Bernstein, Stefan Bielack, Catharina Dhooge (UGent) , Lars Hjorth, Katherine A. Janeway, Meriel Jenney, Mark D. Krailo, et al.

(2022) EUROPEAN JOURNAL OF CANCER. 170. p.209-235
Add to list
- Journal Article
- A1
- open access
Survival and prognosis with osteosarcoma : outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

Sigbjorn Smeland, Stefan S Bielack, Jeremy Whelan, Mark Bernstein, Pancras Hogendoorn, Mark D Krailo, Richard Gorlick, Katherine A Janeway, Fiona C Ingleby, Jakob Anninga, et al.

(2019) EUROPEAN JOURNAL OF CANCER. 109. p.36-50
Add to list
Methotrexate, doxorubicin, and cisplatin (MAP) plus maintenance pegylated interferon alfa-2b versus MAP alone in patients with resectable high-grade osteosarcoma and good histologic response to preoperative MAP : first results of the EURAMOS-1 good respons randomized controlled trial

Stefan S Bielack, Sigbjørn Smeland, Jeremy S Whelan, Neyssa Marina, Gordana Jovic, Jane M Hook, Mark D Krailo, Mark Gebhardt, Zsuzsanna Pápai, James Meyer, et al.

(2015) JOURNAL OF CLINICAL ONCOLOGY. 33(20). p.2279-2287
Add to list
- Journal Article
- A1
- open access
EURAMOS-1, an international randomised study for osteosarcoma : results from pre-randomisation treatment

JS Whelan, SS Bielack, N Marina, S Smeland, G Jovic, JM Hook, M Krailo, J Anninga, T Butterfass-Bahloul, T Böhling, et al.

(2015) ANNALS OF ONCOLOGY. 26(2). p.407-414

Academic Bibliography

Linking EORTC QLQ-C-30 and PedsQL/PEDQOL physical functioning scores in patients with osteosarcoma

Survival and prognosis with osteosarcoma : outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

Methotrexate, doxorubicin, and cisplatin (MAP) plus maintenance pegylated interferon alfa-2b versus MAP alone in patients with resectable high-grade osteosarcoma and good histologic response to preoperative MAP : first results of the EURAMOS-1 good respons randomized controlled trial

EURAMOS-1, an international randomised study for osteosarcoma : results from pre-randomisation treatment

Contents

Support

Contact